Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

University of Manchester

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 3
Average round size
info
The average size of a deal this fund participated in
$5M
Portfolio companies 2
Rounds per year 0.18
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.33
Exits 1
Key employees Soon

Areas of investment

  • Commercial
  • Medical Device
  • Medical
  • Biotechnology
  • Health Care

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of University of Manchester:
Typical Co-investors
University of Manchester is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after University of Manchester:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Angel Equity Holdings LLC -
Austral Capital Chile, Region Metropolitana, Santiago
Beta Catalyst Chiyoda, Japan
Enchant Central, Central Region, Singapore
ENESERVE Japan, Otsu, Shiga Prefecture
Goldrock Capital Center District, Israel, Yerushalayim
Hargreave Hale England, London, United Kingdom
Huntington Ventures California, Irvine, United States
John Hancock Investments Canton, Massachusetts, United States
LJH Partners New York, New York, United States
Monitor Clipper Funds Boston, Massachusetts, United States
Oakmont Corporation California, Los Angeles, United States
Origin Merchant Partners Canada, Ontario, Toronto
Selvedge Venture England, London, United Kingdom
Shanghai Jingzhi Enterprise Management China, Shanghai
Tendence Capital Beijing, Beijing, China
theConstruct Amsterdam, Noord-Holland, The Netherlands
Vision Asset Management Seoul, Seoul-t'ukpyolsi, South Korea
Walmart Arkansas, Bentonville, United States
Xiangcheng Venture Capital China, Jiangsu, Suzhou

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Gelmetix

Biotechnology
Commercial
Health Care
Medical
Medical Device
$4M01 Sep 2018 United Kingdom, England, United Kingdom

Inspired Capital plc

Finance
Financial Services
FinTech
Small and Medium Businesses
$12M20 Oct 2000 Bristol, England, United Kingdom

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent University of Manchester?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 3
Average round size 5M
Rounds per year 0.18
Peak activity year 2018
Lead investments 0
Follow on index 0.33
Exits 1
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Gelmetix

Biotechnology
Commercial
Health Care
Medical
Medical Device
$4M01 Sep 2018 United Kingdom, England, United Kingdom

Inspired Capital plc

Finance
Financial Services
FinTech
Small and Medium Businesses
$12M20 Oct 2000 Bristol, England, United Kingdom
Crunchbase icon

Content report

The following text will be sent to our editors: